Synthesis of β-hydroxyphosphonate and 1, 2-dihydroxy acyclic nucleoside analogs via 1, 3-dipolar cycloaddition strategy
M Ganesan, KM Muraleedharan
Index: Ganesan; Muraleedharan Nucleosides, Nucleotides and Nucleic Acids, 2010 , vol. 29, # 2 p. 91 - 96
Full Text: HTML
Citation Number: 13
Abstract
Synthesis of nucleoside analogs with biomimetically modified “sugar” or the “base” moieties is an area of tremendous interest due to their potential to target pathogens such as human immunodeficiency virus (HIV), hepatitis B virus (HBV), hepatitis C virus (HCV), and cytomegalovirus (CMV). [ 1 1. De Clercq , E. and Holy , A. 2005. Case history: Acyclic nucleoside phosphonates: A key class of antiviral drugs. Nat. Rev. Drug Discovery, 4: 928–940. [CrossRef], [PubMed], [Web of ...
Related Articles:
Asymmetric synthesis of orthogonally protected (2S, 4R)-and (2S, 4S)-4-hydroxyornithine
[Lepine, Renaud; Carbonnelle, Anny-Claude; Zhu, Jieping Synlett, 2003 , # 10 p. 1455 - 1458]
[Barili; Biagi; Giorgi; Livi; Scartoni Journal of Heterocyclic Chemistry, 1991 , vol. 28, # 5 p. 1351 - 1355]
[Barili; Biagi; Giorgi; Livi; Scartoni Journal of Heterocyclic Chemistry, 1991 , vol. 28, # 5 p. 1351 - 1355]